Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Penumbra (PEN). But which of these two stocks presents investors with the better value ...

Fifth-generation vintner Dante Catena is helping lead his family’s expansion into the non-alcoholic wine category through ...

RBC Capital analyst Jack Reynolds-Clark maintained a Buy rating on Alcon yesterday and set a price target of CHF80.00. According to TipRanks, Reynolds-Clark is a 2-star analyst with an average return ...

Non-alcoholic beer brand Crazy Mountain, George Clooney's latest drinks venture, has secured $15m in seed funding in a round ...

A South Carolina couple with a 34-year-old age gap has gone viral after sharing the “non-negotiables” they follow in their marriage. A 26-year-old, Gracen Greagan, and her husband, 60-year-old Kevin ...

Clooney is again working with his fellow Casamigos co-founders.

ABU DHABI, 5th May, 2026 (WAM) -- As part of the celebrations marking 20 years since the establishment of the Sheikh Zayed Book Award (SZBA), the Abu Dhabi Arabic Language Centre (ALC) organised a ...

The Kansas City Royals are back in the win column in walk-off fashion on Friday night. Kyle Isbel hit the game-winning run ...

Culinary arts I and II students at the Advanced Learning Center were recently given a limited number of recipes and 45 ...

Alcon (ALC) stock drops 10% after Q1 revenue miss; see earnings details, margin pressure, FY26 outlook and $1.5B buyback—read the key takeaways now.

Investing.com -- Needham has released prescription trend data for April 2026 covering glaucoma and dry eye medications from Alcon (NYSE:ALC) and Bausch + Lomb (NYSE:BLCO), based on IQVIA tracking.